IN2014DN07895A - - Google Patents
Info
- Publication number
- IN2014DN07895A IN2014DN07895A IN7895DEN2014A IN2014DN07895A IN 2014DN07895 A IN2014DN07895 A IN 2014DN07895A IN 7895DEN2014 A IN7895DEN2014 A IN 7895DEN2014A IN 2014DN07895 A IN2014DN07895 A IN 2014DN07895A
- Authority
- IN
- India
- Prior art keywords
- drug
- exchange resin
- cation exchange
- present
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN7895DEN2014 IN2014DN07895A (he) | 2012-02-21 | 2013-02-21 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN496DE2012 | 2012-02-21 | ||
PCT/IB2013/051432 WO2013124818A1 (en) | 2012-02-21 | 2013-02-21 | Taste masked dispersible tablets |
IN7895DEN2014 IN2014DN07895A (he) | 2012-02-21 | 2013-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN07895A true IN2014DN07895A (he) | 2015-04-24 |
Family
ID=54261187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN7895DEN2014 IN2014DN07895A (he) | 2012-02-21 | 2013-02-21 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20150031647A1 (he) |
EP (1) | EP2816997A1 (he) |
CN (1) | CN104203212A (he) |
AP (1) | AP2014007934A0 (he) |
AU (1) | AU2013223705A1 (he) |
CA (1) | CA2865312A1 (he) |
IN (1) | IN2014DN07895A (he) |
MX (1) | MX2014010038A (he) |
SG (1) | SG11201405053SA (he) |
WO (1) | WO2013124818A1 (he) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10213437B2 (en) | 2014-05-08 | 2019-02-26 | Ctc Bio, Inc. | Pharmaceutical preparation for masked taste oral administration, containing clomipramine |
CN112353802A (zh) * | 2020-11-26 | 2021-02-12 | 山东诚创蓝海医药科技有限公司 | 一种富马酸伏诺拉生掩味组合物及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020032245A1 (en) | 2000-07-27 | 2002-03-14 | Lyn Hughes | Resinate composition |
US20040067216A1 (en) | 2002-02-22 | 2004-04-08 | Karki Shyam B. | Hiv protease inhibitors supported on cation exchange resins for oral administration |
EP2198857A1 (en) * | 2008-12-19 | 2010-06-23 | Ratiopharm GmbH | Oral dispersible tablet |
US20130177520A1 (en) * | 2009-12-31 | 2013-07-11 | Ranbaxy Laboratories Limited | Taste masked dosage forms of bitter tasting anti-retroviral drugs |
-
2013
- 2013-02-21 AU AU2013223705A patent/AU2013223705A1/en not_active Abandoned
- 2013-02-21 IN IN7895DEN2014 patent/IN2014DN07895A/en unknown
- 2013-02-21 WO PCT/IB2013/051432 patent/WO2013124818A1/en active Application Filing
- 2013-02-21 CA CA2865312A patent/CA2865312A1/en not_active Abandoned
- 2013-02-21 SG SG11201405053SA patent/SG11201405053SA/en unknown
- 2013-02-21 AP AP2014007934A patent/AP2014007934A0/xx unknown
- 2013-02-21 CN CN201380016565.2A patent/CN104203212A/zh active Pending
- 2013-02-21 US US14/379,861 patent/US20150031647A1/en not_active Abandoned
- 2013-02-21 EP EP13719304.1A patent/EP2816997A1/en not_active Withdrawn
- 2013-02-21 MX MX2014010038A patent/MX2014010038A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AP2014007934A0 (en) | 2014-09-30 |
EP2816997A1 (en) | 2014-12-31 |
CN104203212A (zh) | 2014-12-10 |
SG11201405053SA (en) | 2014-09-26 |
MX2014010038A (es) | 2014-12-05 |
US20150031647A1 (en) | 2015-01-29 |
AU2013223705A1 (en) | 2014-09-11 |
WO2013124818A1 (en) | 2013-08-29 |
CA2865312A1 (en) | 2013-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4249055A3 (en) | Tofacitinib oral sustained release dosage forms | |
PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
MX2015009058A (es) | Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias. | |
EP3102188A4 (en) | Novel disintegration systems for pharmaceutical dosage forms | |
IN2015DN03984A (he) | ||
PH12016501841A1 (en) | Immunosuppressant formulation | |
HK1205462A1 (en) | Pharmaceutical preparation containing an antivirally active dihydroquinazoline derivative | |
MX2015009045A (es) | Composiciones y metodos para tratar el dolor severo. | |
IN2014DN06966A (he) | ||
IL243786A0 (he) | תרופה המכילה צירוף רוקחי של דולוטגרביר, אמתריציתבין וטנופוביר | |
IN2014MN02236A (he) | ||
MX2016008369A (es) | Composicion farmaceutica que incluye palonosetron. | |
WO2014033526A9 (en) | Pharmaceutical compositions of etoricoxib | |
HUP1300647A2 (hu) | Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik | |
AP2015008208A0 (en) | Pharmaceutical administration forms comprising | |
IN2013MU01985A (he) | ||
MX2016002560A (es) | Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir. | |
TWI800759B (zh) | 醫藥劑型 | |
PH12016500847A1 (en) | Multi-particulate drug delivery system | |
IN2013MU01111A (he) | ||
WO2014125504A3 (en) | Pharmaceutical compositions of febuxostat | |
MX2014006201A (es) | Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse. | |
IN2014DN07895A (he) | ||
MX2015009077A (es) | Composicion estable que contiene fingolimod. | |
IN2013CH04314A (he) |